The largest database of trusted experimental protocols

Ab35958

Manufactured by Abcam
Sourced in United Kingdom

Ab35958 is a recombinant rabbit monoclonal antibody targeted against an undisclosed antigen. The core function of this product is to serve as a research tool for investigating the target antigen in biological systems.

Automatically generated - may contain errors

4 protocols using ab35958

1

Anti-RSV and Anti-SARS-CoV-2 Antibody Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The oxysterol 27OHC complexed with 2-hydroxypropyl-β-cyclodextrin (2HP-βCD:27OHC) was kindly provided by Panoxyvir Ltd (Turin, Italy). The anti-RSV monoclonal antibody Ab35958 was purchased from Abcam (Cambridge, United Kingdom). The secondary antibody peroxidase-conjugated AffiniPure F (ab’)2 Fragment Goat Anti-Mouse IgG (H+L) was purchased from Jackson ImmunoResearch Laboratories Inc. (West Grove, PA, USA). The recombinant antibody mSIP-3022 against SARS-CoV-2 Spike was previously described [17 ].
+ Open protocol
+ Expand
2

Inhibiting RSV Infection with Essential Oils

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the ability to inhibit RSV infection, EO was serially diluted to generate dose-response curves and added to cells. After 2 h, EO was removed and a mixture of EO dilutions and RSV (MOI 0.01 PFU/cell) was added to A549 cells grown as monolayers in a 96-well plate at a density of 7 x 104/well. After 3 hours of incubation at 37°C, monolayers were washed and overlaid with 1.2% of methylcellulose medium containing serial dilutions of EO. Three days post-infection, cells were fixed with cold methanol and acetone for 1 min and subjected to RSV-specific immunostaining using an RSV monoclonal antibody (Ab35958, Abcam, Cambridge, UK) and the UltraTech HRP streptavidin-biotin detection system (Beckman Coulter, Marseille, France). Immunostained syncytia were counted and the percent inhibition of virus infectivity determined by comparing the number of plaques in treated wells with the number in untreated control wells. 50% effective concentration (EC50) values and 95% CIs were determined using Prism software. All data were generated from duplicate wells in at least three independent experiments.
+ Open protocol
+ Expand
3

Propagation and Quantification of Clinically Relevant Viruses

Check if the same lab product or an alternative is used in the 5 most similar protocols
The neurovirulent strains LV (21 (link)) and MS (ATCC VR-540) of HSV-1 and HSV-2, were propagated in Vero cells at 37°C (22 (link)). HRhV 1A (ATCC VR-1559) was propagated in HeLa cells, at 33°C. HSV-1, HSV-2, and HRhV titers were determined by the standard plaque method and expressed as plaque-forming unit (PFU)/ml. A bacterial artificial chromosome (BAC)-derived HCMV strain Towne incorporating the green fluorescent protein (GFP) sequence (23 (link)) was propagated on HFF-1 and viral titres were determined by fluorescent focus assay. RSV strain A2 (ATCC VR-1540) was propagated in Hep-2 and titrated by the indirect immunoperoxidase staining procedure using an RSV monoclonal antibody (Ab35958, Abcam) (24 (link)). Human HRoV strain Wa (ATCC VR-2018) was activated with 5 μg/ml of porcine pancreatic trypsin type IX (Sigma) for 30 min at 37°C and propagated in MA104 cells by using MEM containing 0.5 μg of trypsin per ml. HCMV, RSV and HRoV titers were expressed as focus-forming units (FFU)/ml. Virus stocks were maintained frozen (-80°C).
+ Open protocol
+ Expand
4

RSV Infection Assay in HeP-2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeP-2 cells were pre-plated in a 96-well plate. The following day increasing concentrations of compounds were mixed with RSV (MOI 0.005) and incubated for 1 h at 37°C. The mixtures were subsequently added to the cells, which were then incubated at 37°C for 3 h; monolayers were then washed and overlaid with 1.2% methylcellulose medium. 72 h later cells were fixed and subjected to specific immunostaining using an RSV monoclonal antibody (Ab35958; Abcam, Cambridge, United Kingdom) in order to visualize syncytia. Percentages of infection were calculated by comparing numbers of syncytia in treated and untreated wells.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!